Skip to content

Does Phosphatidic Acid Reduce Testosterone? A Scientific Review

4 min read

According to a 1994 study using isolated rat Leydig cells, agents that increase phosphatidic acid inhibited LH-induced testosterone production. This has raised questions for some, but does phosphatidic acid reduce testosterone in humans when taken as a supplement? This article explores the current evidence, distinguishing between lab findings and real-world results.

Quick Summary

Current evidence suggests phosphatidic acid supplementation does not significantly alter anabolic hormone levels, including testosterone, in humans. Research distinguishes between cellular mechanisms observed in labs and practical effects from oral intake.

Key Points

  • In vitro study findings: A 1994 study on isolated rat cells found that increased phosphatidic acid inhibited LH-induced testosterone production, but this result is not applicable to human supplementation.

  • Human research shows no reduction: Human trials on oral phosphatidic acid supplementation for muscle growth have not reported any significant reductions in testosterone or other hormonal side effects.

  • PA and mTOR pathway: Phosphatidic acid's primary mechanism for increasing muscle mass involves activating the mTOR signaling pathway, which is separate from the endocrine system's testosterone regulation.

  • Differing mechanisms: The way PA affects muscle cells is distinct from the LH-induced testosterone synthesis pathway in Leydig cells, which explains the difference between lab-cell results and human outcomes.

  • PA is generally safe: Phosphatidic acid supplementation is considered safe for healthy individuals at recommended doses, with only minor, non-hormonal side effects like gastrointestinal discomfort sometimes reported.

  • Distinguish research contexts: It is crucial to distinguish between cellular research on isolated rat cells and results from human studies involving oral supplementation, as the findings are not interchangeable.

In This Article

Understanding Phosphatidic Acid's Role

Phosphatidic acid (PA) is a crucial lipid messenger molecule found naturally within the body and is also available as a dietary supplement. Its primary function, and the reason for its popularity in the fitness community, is its role in activating the mechanistic target of rapamycin (mTOR) pathway. The mTOR pathway is a key regulator of muscle protein synthesis and cell growth, making PA an attractive supplement for those looking to increase muscle mass and strength.

The In Vitro Rat Study That Sparked Concern

In the 1990s, a study was conducted on isolated rat Leydig cells—the cells responsible for producing testosterone in the testicles. The researchers introduced agents that increased phosphatidic acid levels within these isolated cells and observed a dose-dependent inhibition of testosterone production, specifically the portion stimulated by luteinizing hormone (LH).

Key findings from the 1994 study:

  • Increased intracellular PA in isolated rat Leydig cells inhibited LH-induced testosterone production.
  • The inhibition occurred at a point in the synthetic pathway before the first enzyme in testosterone production, but after the generation of cAMP.
  • This suggested a causal relationship between high intracellular PA levels and the inhibition of testosterone in this specific, isolated cell environment.

It is critical to understand the limitations of this study. It was performed on isolated rat cells in a laboratory, not on living humans. The concentration of PA-increasing agents and the controlled environment are not representative of how a human body processes and uses an oral supplement.

Human Supplementation Trials and Hormonal Effects

Since the early cellular research, numerous human trials have investigated the effects of oral phosphatidic acid supplementation, mostly in the context of resistance training. The vast majority of these studies focus on outcomes related to muscle growth, such as lean body mass and strength, and do not report any significant or negative hormonal changes, including to testosterone levels.

For example, studies have shown that 750mg of daily PA supplementation combined with resistance training can increase lean body mass and strength in trained men compared to a placebo group. Despite these anabolic effects, these studies do not indicate a suppression of testosterone. This is a crucial point, as the mechanism for muscle growth through mTOR activation is separate from the endocrine pathways that regulate testosterone production.

Transparent Labs, a supplement company, references relevant studies and states, "there is no conclusive evidence that phosphatidic acid significantly alters the endocrine response to resistance training". The consensus from human research is that while PA successfully activates the mTOR pathway for muscle protein synthesis, it does not appear to interfere with the body's hormonal systems in a way that would reduce testosterone.

Potential Explanations for the Discrepancy

The difference between the isolated rat cell study and human supplementation outcomes can be attributed to several factors:

  • Method of Delivery: The 1994 study used specific agents to artificially increase intracellular PA in a closed, isolated system. In humans, orally consumed PA is metabolized and interacts with the body in a much more complex, systemic way.
  • Concentration: The high concentrations of PA used in the lab setting may not be achievable or relevant in the context of standard oral supplementation doses.
  • Pathway Specificity: PA's role in activating mTOR for muscle growth appears to be distinct from the hormonal cascade (LH stimulation of Leydig cells) that regulates testosterone synthesis.

How Testosterone and PA's Primary Pathways Differ

To fully appreciate why PA does not reduce testosterone in humans, it helps to understand the two distinct biological pathways involved.

Comparison of Pathways: Testosterone Synthesis vs. mTOR Activation

Feature Testosterone Synthesis (Androgenic) Phosphatidic Acid (mTOR Activation)
Initiating Signal Luteinizing Hormone (LH) from the pituitary gland signals Leydig cells in the testicles. Mechanical tension from resistance exercise and amino acid availability.
Key Organ/Tissue Leydig cells within the testicles. Skeletal muscle tissue.
Signal Transduction LH-binding leads to cAMP generation, followed by other steps to convert cholesterol into testosterone. PA is produced via phospholipase D (PLD) and directly binds to and activates the mTOR protein.
End Result Production of testosterone. Increased muscle protein synthesis (MPS).

Is Phosphatidic Acid Safe? What are the Side Effects?

PA is generally considered safe for healthy individuals when used at recommended dosages. Clinical trials have reported no serious adverse events associated with its use. Any reported side effects are typically mild and may include minor gastrointestinal discomfort, such as bloating, gas, or nausea, especially when taken in higher doses.

One potential, though not hormonal, interaction involves the timing of supplementation. Some research suggests taking PA with whey protein might blunt its effects on muscle protein synthesis, so it's often recommended to separate the dosages by a few hours.

Conclusion: Does Phosphatidic Acid Reduce Testosterone?

No, based on current human research, there is no evidence that phosphatidic acid supplementation reduces testosterone levels. The concerns arose from a decades-old study on isolated rat cells, which does not accurately reflect the complex biological interactions in living humans. While the in vitro study showed a potential inhibitory effect in a highly controlled environment, subsequent human trials have not found any significant negative hormonal effects from oral PA supplementation. Instead, the research consistently points to PA's primary mechanism for enhancing muscle growth and strength through the mTOR pathway, which is separate from the body's testosterone production system. For individuals considering PA to support muscle-building goals, it is considered a safe and effective supplement with no documented link to reduced testosterone.

Frequently Asked Questions

No, human clinical research on oral phosphatidic acid supplementation has not shown it to lower testosterone levels. Concerns about this stemmed from an older study on isolated rat cells, not human subjects.

The main function of phosphatidic acid (PA) is to activate the mTOR signaling pathway, a key regulator of muscle protein synthesis, leading to muscle growth and repair.

The mTOR pathway controls cell growth and protein synthesis. Phosphatidic acid directly binds to and activates the mTOR protein, particularly following resistance training, to stimulate muscle-building processes.

Human studies on PA supplementation have largely found no conclusive evidence of significant alterations to the overall endocrine response, including other anabolic hormones.

Phosphatidic acid is generally well-tolerated. Potential minor side effects can include mild gastrointestinal issues like bloating, gas, or nausea, particularly with higher doses.

The inhibition was observed in a 1994 study using isolated rat testicle cells exposed to PA-increasing agents, not in a living human body. The artificial environment and method of exposure do not reflect how oral PA supplementation works.

Yes, PA is often stacked with other supplements like creatine. However, some research suggests separating PA from whey protein intake by a few hours to maximize its effects on muscle protein synthesis.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.